摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3-Fluoro-4-(4-(2-morpholinobenzoyl)piperazin-1-yl)phenyl)ethanone | 1079816-90-2

中文名称
——
中文别名
——
英文名称
1-(3-Fluoro-4-(4-(2-morpholinobenzoyl)piperazin-1-yl)phenyl)ethanone
英文别名
1-[3-fluoro-4-[4-(2-morpholin-4-ylbenzoyl)piperazin-1-yl]phenyl]ethanone
1-(3-Fluoro-4-(4-(2-morpholinobenzoyl)piperazin-1-yl)phenyl)ethanone化学式
CAS
1079816-90-2
化学式
C23H26FN3O3
mdl
——
分子量
411.476
InChiKey
UUPNMBYEWFVNFJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    30
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    53.1
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    2-(4-吗啉基)苯甲酸1-(3-氟-4-哌嗪-1-基-苯基)-乙酮 在 O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 、 N,N-二异丙基乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 1-(3-Fluoro-4-(4-(2-morpholinobenzoyl)piperazin-1-yl)phenyl)ethanone
    参考文献:
    名称:
    Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors
    摘要:
    Screening of the Roche compound library led to the identification of the benzoylpiperazine 7 as a structurally novel GlyT1 inhibitor. The SAR which was developed in this series resulted in the discovery of highly potent compounds displaying excellent selectivity against the GlyT2 isoform, drug-like properties, and in vivo efficacy after oral administration. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.07.086
点击查看最新优质反应信息

文献信息

  • Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors
    作者:Emmanuel Pinard、Daniela Alberati、Edilio Borroni、Holger Fischer、Dominik Hainzl、Synèse Jolidon、Jean-Luc Moreau、Robert Narquizian、Matthias Nettekoven、Roger D. Norcross、Henri Stalder、Andrew W. Thomas
    DOI:10.1016/j.bmcl.2008.07.086
    日期:2008.9
    Screening of the Roche compound library led to the identification of the benzoylpiperazine 7 as a structurally novel GlyT1 inhibitor. The SAR which was developed in this series resulted in the discovery of highly potent compounds displaying excellent selectivity against the GlyT2 isoform, drug-like properties, and in vivo efficacy after oral administration. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多